Jasper Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-33.7M | $-33.7M | — | $1.0M |
| FY2022 | $-45.9M | $-45.9M | — | $4.1M |
| FY2023 | $-52.1M | $-52.1M | — | $5.2M |
| FY2024 | $-62.6M | $-62.6M | — | $6.6M |
| FY2025 | $-77.2M | $-77.2M | — | $6.7M |